163 related articles for article (PubMed ID: 11803160)
1. Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals.
Fissell WH; Dyke DB; Weitzel WF; Buffington DA; Westover AJ; MacKay SM; Gutierrez JM; Humes HD
Blood Purif; 2002; 20(1):55-60. PubMed ID: 11803160
[TBL] [Abstract][Full Text] [Related]
2. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
Fissell WH; Lou L; Abrishami S; Buffington DA; Humes HD
J Am Soc Nephrol; 2003 Feb; 14(2):454-61. PubMed ID: 12538747
[TBL] [Abstract][Full Text] [Related]
3. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cytokine response and survival time by bioartificial kidney therapy in acute uremic pigs with multi-organ dysfunction.
Wang H; Zhang M; Wang X; Mao H; Ying X; Zhu W; Sun C; Jiang C
Int J Artif Organs; 2010 Aug; 33(8):526-34. PubMed ID: 20872347
[TBL] [Abstract][Full Text] [Related]
5. The bioartificial kidney in the treatment of acute renal failure.
Humes HD; Fissell WH; Weitzel WF
Kidney Int Suppl; 2002 May; (80):121-5. PubMed ID: 11982826
[TBL] [Abstract][Full Text] [Related]
6. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure.
Humes HD; Weitzel WF; Bartlett RH; Swaniker FC; Paganini EP
Blood Purif; 2003; 21(1):64-71. PubMed ID: 12566664
[TBL] [Abstract][Full Text] [Related]
7. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells.
Humes HD; Fissell WH; Weitzel WF; Buffington DA; Westover AJ; MacKay SM; Gutierrez JM
Am J Kidney Dis; 2002 May; 39(5):1078-87. PubMed ID: 11979353
[TBL] [Abstract][Full Text] [Related]
8. Renal cell therapy in the treatment of patients with acute and chronic renal failure.
Humes HD; Weitzel WF; Fissell WH
Blood Purif; 2004; 22(1):60-72. PubMed ID: 14732813
[TBL] [Abstract][Full Text] [Related]
9. Renal assist device and treatment of sepsis-induced acute kidney injury in intensive care units.
Issa N; Messer J; Paganini EP
Contrib Nephrol; 2007; 156():419-27. PubMed ID: 17464153
[TBL] [Abstract][Full Text] [Related]
10. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure.
Humes HD; Weitzel WF; Bartlett RH; Swaniker FC; Paganini EP; Luderer JR; Sobota J
Kidney Int; 2004 Oct; 66(4):1578-88. PubMed ID: 15458454
[TBL] [Abstract][Full Text] [Related]
11. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection.
Shum HP; Chan KC; Kwan MC; Yan WW
Hong Kong Med J; 2013 Dec; 19(6):491-7. PubMed ID: 23650198
[TBL] [Abstract][Full Text] [Related]
12. The bioartificial kidney in the treatment of acute kidney injury.
Song JH; Humes HD
Curr Drug Targets; 2009 Dec; 10(12):1227-34. PubMed ID: 19715535
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure.
Bellomo R; Tipping P; Boyce N
Ren Fail; 1995 Jul; 17(4):457-66. PubMed ID: 7569116
[TBL] [Abstract][Full Text] [Related]
14. The bioartificial renal tubule assist device to enhance CRRT in acute renal failure.
Humes HD; MacKay SM; Funke AJ; Buffington DA
Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S28-31. PubMed ID: 9372976
[TBL] [Abstract][Full Text] [Related]
15. Cytokine patterns in patients who undergo hemofiltration for treatment of multiple organ failure.
Koperna T; Vogl SE; Pöschl GP; Hamilton G; Röder G; Germann P
World J Surg; 1998 May; 22(5):443-7; discussion 448. PubMed ID: 9564285
[TBL] [Abstract][Full Text] [Related]
16. Blood and plasma treatments: the rationale of high-volume hemofiltration.
Honoré PM; Joannes-Boyau O; Gressens B
Contrib Nephrol; 2007; 156():387-95. PubMed ID: 17464149
[TBL] [Abstract][Full Text] [Related]
17. The bioartificial kidney and bioengineered membranes in acute kidney injury.
Ding F; Humes HD
Nephron Exp Nephrol; 2008; 109(4):e118-22. PubMed ID: 18802374
[TBL] [Abstract][Full Text] [Related]
18. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs.
Ullrich R; Roeder G; Lorber C; Quezado ZM; Kneifel W; Gasser H; Schlag G; Redl H; Germann P
Anesthesiology; 2001 Aug; 95(2):428-36. PubMed ID: 11506117
[TBL] [Abstract][Full Text] [Related]
19. Renal cell therapy and beyond.
Song JH; Humes HD
Semin Dial; 2009; 22(6):603-9. PubMed ID: 20017829
[TBL] [Abstract][Full Text] [Related]
20. Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis.
Yekebas EF; Strate T; Zolmajd S; Eisenberger CF; Erbersdobler A; Saalmüller A; Steffani K; Busch C; Elsner HA; Engelhardt M; Gillesen A; Meins J; The M; Knoefel WT; Izbicki JR
Kidney Int; 2002 Nov; 62(5):1806-18. PubMed ID: 12371983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
